[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.52.4. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 4,828
Citations 0
Correction
May 2018

Error in Author Byline

JAMA Cardiol. 2018;3(5):445. doi:10.1001/jamacardio.2018.1067

In the Original Investigation titled “Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial,”1 published online March 11, 2018, there were errors in the author byline. Instead of “The Writing Committee for the TREAT Study Group,” the author byline should read as follows: “Otavio Berwanger, MD, PhD; Jose C. Nicolau, MD, PhD; Antonio C. Carvalho, MD, PhD; Lixin Jiang, MD, PhD; Shaun G. Goodman, MD, PhD; Stephen J. Nicholls, MD, PhD; Alexander Parkhomenko, MD, PhD; Oleg Averkov, MD, PhD; Carlos Tajer, MD, PhD; Germán Malaga, MD, PhD; Jose F. K. Saraiva, MD, PhD; Francisco A. Fonseca, MD, PhD; Fábio A. De Luca, MD, PhD; Helio P. Guimaraes, MD, PhD; Pedro G. M. de Barros e Silva, MD, MHS, PhD; Lucas P. Damiani, MSc; Denise M. Paisani, PhD; Camila M. R. Lasagno, BSc; Carolina T. Candido, PharmD; Nanci Valeis, Dr; Diogo D. F. Moia, PharmD; Leopoldo S. Piegas, MD, PhD; Christopher B. Granger, MD, PhD; Harvey D. White, MD, PhD; Renato D. Lopes, MD, MHS, PhD; for the TREAT Study Group.” This article was corrected online.

References
1.
Berwanger  O, Nicolau  JC, Carvalho  AC,  et al.  Ticagrelor vs clopidogrel after fibrinolytic therapy in patients with st-elevation myocardial infarction: a randomized clinical trial [published online March 11, 2018].  JAMA Cardiol. doi:10.1001/jamacardio.2018.0612Google Scholar
×